There are 3161 resources available
Invited Discussant 615MO and 616MO
Presenter: Christophe Massard
Session: Mini oral session: Developmental therapeutics
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Eva Kimby
Session: CAR T cells and bispecifics
Resources:
Webcast
Discussion
Session: Treatment of lobular breast cancer (ILC): From pitfalls to opportunities
Resources:
Webcast
Q&A and discussion
Session: Next generation immunotherapies in thoracic malignancies
Resources:
Webcast
1816O - A multicentre, randomized, double-blind, placebo-controlled study of olanzapine-based triplet antiemetic therapy for prevention of delayed and persistent nausea and vomiting induced by trastuzumab deruxtecan in patients with metastatic breast cancer: ERICA study (WJOG14320B)
Presenter: Hitomi Sakai
Session: Proffered paper session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
510MO - Long-term survival and organ preservation with pembrolizumab in localized MSI-H/dMMR solid tumors
Presenter: Kaysia Ludford
Session: Mini oral session: GI tumours, lower
Resources:
Abstract
Slides
Webcast
64O - Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay for MRD in head and neck cancers
Presenter: Shao Hui Huang
Session: Proffered paper session 1: Basic science & Translational research
Resources:
Abstract
Slides
Webcast
LBA30 - ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)
Presenter: Bradley Monk
Session: Proffered paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant 508MO and 510MO
Presenter: Dirk Arnold
Session: Mini oral session: GI tumours, lower
Resources:
Webcast
Conclusions and perspectives
Presenter: Nathalie Chaput-Gras
Session: Next generation immunotherapies in thoracic malignancies
Resources:
Slides
Webcast